Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies. uri icon

authors

  • Connor, Matthew P
  • Pratz, Keith W
  • Timlin, Colleen
  • Freyer, Craig W
  • Carulli, Alison
  • Catania, Christopher
  • Smith, Jacqueline
  • Hollander, Lauren
  • Zebrowski, Alexis M
  • Stadtmauer, Edward A
  • Porter, David L
  • Loren, Alison W
  • Frey, Noelle V
  • Hexner, Elizabeth O
  • Martin, Mary Ellen
  • Gill, Saar I
  • Luger, Selina M
  • Mangan, James K
  • Perl, Alexander E
  • Shannon R. McCurdy, MD

publication date

  • November 4, 2022